Radiko Holdings Corp. Aktie Canadian Securities Exchange
Aktien
A2QAAM
CA75034R1029
JUJU
Pharmazeutika
Umsatz 2018 | 106’584 146’702 95’445.97 | Umsatz 2019 | 5.18 Mio. 7.13 Mio. 4.64 Mio. | Marktwert | 6.17 Mio. 8.49 Mio. 5.52 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -4 Mio. -5.51 Mio. -3.58 Mio. | Nettoergebnis 2019 | -10 Mio. -13.76 Mio. -8.96 Mio. | EV / Sales 2018 | 101 x |
Nettoschuld 2018 | 258’657 356’015 231’627 | Nettoschuld 2019 | 1.98 Mio. 2.73 Mio. 1.77 Mio. | EV / Sales 2019 | 1.57 x |
KGV 2018 |
-1.5
x | KGV 2019 |
-0.53
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 96.73% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10.12.19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12.11.19 |
% 1. Jan. | Kap. | |
---|---|---|
+45.82% | 765 Mrd. | |
+40.95% | 632 Mrd. | |
-6.16% | 354 Mrd. | |
+19.86% | 331 Mrd. | |
+9.32% | 299 Mrd. | |
+18.45% | 248 Mrd. | |
+11.88% | 216 Mrd. | |
-0.78% | 219 Mrd. | |
+5.90% | 164 Mrd. |